Adamas Pharmaceuticals reported 31.53M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Acorda Therapeutics ACOR:US $ 54.46M 6.99M
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Aerie Pharmaceuticals AERI:US $ 61.69M 3M
Aptinyx Inc APTX:US $ 21.21M 1.34M
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Flexion Therapeutics FLXN:US $ 44.98M 73K
GlaxoSmithKline GSK:LN 7.14B 722M
Glaxosmithkline GSK:US 7.14B 722M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Intra Cellular Therapies ITCI:US $ 99.53M 10.34M
Marinus Pharmaceuticals MRNS:US $ 29.28M 3.89M
Merk MRK:US $ 8328M 1460M
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novartis NOVN:VX 10.13B 319M
Omeros OMER:US $ 48.26M 4.58M
Prothena PRTA:US 29.95M 2.17M
Revance Therapeutics RVNC:US $ 92.47M 3.33M
Teva Pharmaceutical TEVA:IT 3.26B 64M
Zogenix ZGNX:US $ 76.48M 2.26M